Evidence map›Paper›PMID 41674960›Full record

ArticleTranslational cancer research2026

Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort study.

Jacopo Conforti, Alisha Sattar, Andreas Zouridis, Sarah Smyth, Ahmed Darwish, Negin Sadeghi, Mostafa Abdalla, Loryn Caulfield, Sally Trent, Federico Ferrari and 4 more

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jacopo Conforti *Department of Gynaecology Oncology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID https://orcid.org/0009-0004-2831-2134
Alisha Sattar *Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0001-7216-3560
Andreas ZouridisOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Sarah SmythWexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK.
Ahmed DarwishOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Negin SadeghiOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Mostafa AbdallaOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Loryn CaulfieldOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Sally TrentOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Federico FerrariDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.ORCID https://orcid.org/0000-0001-7065-2432
Christina PappaOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Sean KehoeOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Susan AddleyUniversity Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Hooman Soleymani MajdDepartment of Gynaecology Oncology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID https://orcid.org/0000-0003-3293-5321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial cancer with aggressive characteristics. The aim of our cohort analysis was to examine and present risk factors for recurrence and mortality. Methods: The study is a retrospective analysis led from April 2010 and November 2019. Women older than 18 years, with a histopathological diagnosis of serous carcinoma (SC) and suitable for surgery were included in this study. Univariate and multivariate Cox proportional hazards analysis was conducted to assess individual risk factors for both recurrence and mortality. Survival rates were calculated using Kaplan-Meier curves and compared using log-rank tests. Results: One hundred and eighteen cases of SC were surgically managed. For the entire cohort, 5-year overall survival (OS) was 41.6%, while 5-year disease-free survival (DFS) was 60.7%. Advanced stages had the worst survival and recurrence rate (P=0.001 and 0.01, respectively). Univariate analysis revealed an association with a high risk of mortality for myometrial invasion, cervical, parametrial and lymphovascular space invasion (LVSI) and adnexa involvement, whereas only cervical, lymphovascular and parametrium invasion were associated. However, the multivariate analysis confirmed the cervical invasion as a poor predictor for survival with a hazard ratio of 2.230 (95% confidence interval: 1.252-3.971; P=0.006). Conclusions: UPSC is an aggressive subtype of endometrial cancer where even early stages tend to recur and deteriorate the prognosis. Cervical involvement was the only risk factor associated with increased mortality, while myometrial invasion and LVSI were not confirmed in the multivariate analysis.

Indexed as

endometrial cancerserous carcinoma (SC)serous uterine carcinomaUterine cancer

Identifiers

PMID41674960
PMCPMC12885917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.